GENERATION BIO CO (GBIO)

US37148K1007 - Common Stock

0.88  -0.04 (-4.35%)

Premarket: 0.97 +0.09 (+10.23%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
5.904M18.464M
212.74%
7.239M
-60.79%
9.557M
32.02%
10.921M
14.27%
11.487M
5.18%
23.658M
105.95%
99.193M
319.28%
175.32M
76.75%
443.2M
152.79%
EBITDA
YoY % growth
-114.57M
-47.49%
-130.25M
-13.69%
-133.3M
-2.34%
-136.68M
-2.54%
-85.68M
37.31%
-87.72M
-2.38%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-119.1M
-46.84%
-135.38M
-13.67%
-138.563M
-2.35%
-135.798M
2.00%
-92.064M
32.20%
-95.414M
-3.64%
-93.987M
1.50%
-62.681M
33.31%
-48.507M
22.61%
-53.011M
-9.29%
13.117M
124.74%
116.59M
788.85%
Operating Margin
N/AN/A-2,346.93%-735.47%-1,271.78%-998.37%-860.61%-545.67%-205.03%-53.44%7.48%26.31%
EPS
YoY % growth
-2.11
26.90%
-2.35
-11.37%
-1.96
16.60%
-1.88
4.24%
-1.12
40.51%
-0.92
17.96%
-0.68
25.39%
-0.77
-11.94%
-0.70
8.00%
0.39
155.07%
0.21
-44.74%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.31
41.44%
-0.31
72.06%
-0.32
-1.84%
-0.32
-40.58%
-0.33
-5.08%
-0.25
20.46%
-0.25
21.16%
-0.15
54.89%
-0.14
58.09%
Revenue
Q2Q % growth
1.938M
-32.66%
1.904M
-53.09%
1.904M
-53.46%
1.87M
-75.24%
1.87M
-3.51%
113.22K
-94.05%
113.22K
-94.05%
113.22K
-93.95%
113.22K
-93.95%
EBITDA
Q2Q % growth
-19.38M
41.55%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-24.243M
36.90%
-23.97M
-15.77%
-23.97M
-9.89%
-24.99M
-49.51%
-24.99M
-3.08%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.23
46.51%
-0.290.0620.20%
Q2 2024
Q2Q % growth
-0.31
34.04%
-0.28-0.03-9.16%
Q1 2024
Q2Q % growth
-1.12
-111.32%
-0.42-0.70-169.03%
Q4 2023
Q2Q % growth
-0.53
3.64%
-0.46-0.07-15.84%
Q3 2023
Q2Q % growth
-0.43
18.87%
-0.520.0916.52%
Q2 2023
Q2Q % growth
-0.47
28.79%
-0.510.047.26%
Q1 2023
Q2Q % growth
-0.53
13.11%
-0.47-0.06-11.91%
Q4 2022
Q2Q % growth
-0.55
-1.85%
-0.590.046.83%
Q3 2022
Q2Q % growth
-0.53
5.36%
-0.680.1522.61%
Q2 2022
Q2Q % growth
-0.66
-20.00%
-0.64-0.02-3.89%
Q1 2022
Q2Q % growth
-0.61
-32.61%
-0.54-0.07-13.91%
Q4 2021
Q2Q % growth
-0.54
-100.00%
-0.580.047.12%
Q3 2021
Q2Q % growth
-0.56
-21.74%
-0.570.011.37%
Q2 2021
Q2Q % growth
-0.55
63.33%
-0.48-0.07-15.43%
Q1 2021
Q2Q % growth
-0.46 -0.460.00-0.22%
Q4 2020
Q2Q % growth
-0.27 -0.510.2447.41%
Q3 2020
Q2Q % growth
-0.46 -0.460.000.34%
Q2 2020
Q2Q % growth
-1.50 -0.61-0.89-144.08%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
7.554M
252.00%
1.92M5.634M293.44%
Q2 2024
Q2Q % growth
4.091M
364.89%
1.999M2.092M104.65%
Q1 2024
Q2Q % growth
4.059M 1.958M2.101M107.30%
Q4 2023
Q2Q % growth
2.878M 877.2K2.001M228.09%
Q3 2023
Q2Q % growth
2.146M 1.115M1.031M92.47%
Q2 2023
Q2Q % growth
880K 3.622M-2.742M-75.70%
Q1 2023
Q2Q % growth
8.075M-8.075M-100.00%
Q2 2022
Q2Q % growth
1.53M-1.53M-100.00%
Q1 2022
Q2Q % growth
1.53M-1.53M-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -18.07% 0% 9.57%
Revenue0% -5.92% 4.72% 56.87%